Pepscan Presto B.V.
- UEI
- WUEBKGTXE2K8
- CAGE
- H2FS8
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- biosynth.com
- Founded
- 1965
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Custom peptide synthesis - conformational epitope mapping | National Institute of Allergy and Infectious Diseases | $11,322 | |
| Acquisition, characterization, and optimization of constrained peptides targeting glypican, in support of the u.s.… | National Cancer Institute | $81,460 | |
| Screening cost for 10 samples with | Bureau of Medicine and Surgery | $10,615 | |
| Pepchiptm kinomics slides | NIAID DEA OA Acquisitions | $7,900 | |
| Pepscan presto b.v.:1240256 [15-016646] | Office of the Chief Operating Officer | $7,898 |
About Pepscan Presto B.V.
Pepscan Presto B.V. is a foreign-owned, for-profit corporate entity registered to receive federal awards. According to its website, Pepscan is a premier provider of peptide-based products and services, with over 25 years of experience and a range of patented technologies and facilities for the development and manufacturing of peptides.
Pepscan Presto B.V. has been awarded several prime federal contracts to provide peptide synthesis and related services to various agencies within the Department of Health and Human Services (HHS). For the National Institute of Allergy and Infectious Diseases (NIAID), Pepscan provided custom peptide synthesis for conformational epitope mapping through a $11,322 purchase order awarded in July 2022. The National Cancer Institute (NCI) awarded Pepscan an $81,460 purchase order in September 2020 for the acquisition, characterization, and optimization of constrained peptides targeting glypican. Additionally, the Bureau of Medicine and Surgery within the Department of the Navy awarded Pepscan a $10,615.09 purchase order in July 2019 for screening cost services involving 10 samples. These contracts demonstrate Pepscan's expertise in peptide synthesis, characterization, and optimization services for various biomedical research and development projects within the federal government.
Quick answers
What is Pepscan Presto B.V.'s UEI?
Pepscan Presto B.V.'s Unique Entity ID (UEI) in SAM.gov is WUEBKGTXE2K8.
What is Pepscan Presto B.V.'s CAGE code?
Pepscan Presto B.V.'s CAGE code is H2FS8.
What is Pepscan Presto B.V.'s primary NAICS code?
Pepscan Presto B.V.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Pepscan Presto B.V. registered in SAM.gov?
Pepscan Presto B.V.'s SAM.gov registration expired on March 16, 2023.
What is Pepscan Presto B.V.'s most recent federal award?
Pepscan Presto B.V.'s most recent federal contract award is Custom peptide synthesis - conformational epitope mapping (75N93022P00893), from National Institute of Allergy and Infectious Diseases, on July 25, 2022.
On GovTribe
See Pepscan Presto B.V.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors